Acknowledgement
This work was supported by grants from the National Research Foundation of Korea (NRF), funded by the Korean government (MSIP) (NRF-2017R1E1A1A01074733, NRF-2017M3A9B6061509, NRF-2017M3C9A6047620, NRF-2019R1A5A2026045, and NRF-2019R1I1A1A01057206).
References
- Ahmed, M.B., Islam, S.U., Sonn, J.K., and Lee, Y.S. (2020). PRP4 kinase domain loss nullifies drug resistance and epithelial-mesenchymal transition in human colorectal carcinoma cells. Mol. Cells 43, 662-670. https://doi.org/10.14348/molcells.2020.2263
- Bid, H.K., Roberts, R.D., Manchanda, P.K., and Houghton, P.J. (2013). RAC1: an emerging therapeutic option for targeting cancer angiogenesis and metastasis. Mol. Cancer Ther. 12, 1925-1934. https://doi.org/10.1158/1535-7163.MCT-13-0164
- Bright, M.D., Clarke, P.A., Workman, P., and Davies, F.E. (2018). Oncogenic RAC1 and NRAS drive resistance to endoplasmic reticulum stress through MEK/ERK signalling. Cell. Signal. 44, 127-137. https://doi.org/10.1016/j.cellsig.2018.01.004
- Cubillos-Ruiz, J.R., Bettigole, S.E., and Glimcher, L.H. (2017). Tumorigenic and immunosuppressive effects of endoplasmic reticulum stress in cancer. Cell 168, 692-706. https://doi.org/10.1016/j.cell.2016.12.004
- De, P., Aske, J.C., and Dey, N. (2019). RAC1 takes the lead in solid tumors. Cells 8, 382. https://doi.org/10.3390/cells8050382
- Ebi, H., Costa, C., Faber, A.C., Nishtala, M., Kotani, H., Juric, D., Della Pelle, P., Song, Y., Yano, S., Mino-Kenudson, M., et al. (2013). PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1. Proc. Natl. Acad. Sci. U. S. A. 110, 21124-21129. https://doi.org/10.1073/pnas.1314124110
- Effendi, K., Yamazaki, K., Mori, T., Masugi, Y., Makino, S., and Sakamoto, M. (2013). Involvement of hepatocellular carcinoma biomarker, cyclaseassociated protein 2 in zebrafish body development and cancer progression. Exp. Cell Res. 319, 35-44. https://doi.org/10.1016/j.yexcr.2012.09.013
- Farre, D., Roset, R., Huerta, M., Adsuara, J.E., Rosello, L., Alba, M.M., and Messeguer, X. (2003). Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 31, 3651-3653. https://doi.org/10.1093/nar/gkg605
- Fu, J., Li, M., Wu, D.C., Liu, L.L., Chen, S.L., and Yun, J.P. (2015). Increased expression of CAP2 indicates poor prognosis in hepatocellular carcinoma. Transl. Oncol. 8, 400-406. https://doi.org/10.1016/j.tranon.2015.08.003
- Jee, B.A., Choi, J.H., Rhee, H., Yoon, S., Kwon, S.M., Nahm, J.H., Yoo, J.E., Jeon, Y., Choi, G.H., Woo, H.G., et al. (2019). Dynamics of genomic, epigenomic, and transcriptomic aberrations during stepwise hepatocarcinogenesis. Cancer Res. 79, 5500-5512. https://doi.org/10.1158/0008-5472.CAN-19-0991
- Jiang, Q.H., Wang, A.X., and Chen, Y. (2014). Radixin enhances colon cancer cell invasion by increasing MMP-7 production via Rac1-ERK pathway. ScientificWorldJournal 2014, 340271.
- Kosmas, K., Eskandarnaz, A., Khorsandi, A.B., Kumar, A., Ranjan, R., Eming, S.A., Noegel, A.A., and Peche, V.S. (2015). CAP2 is a regulator of the actin cytoskeleton and its absence changes infiltration of inflammatory cells and contraction of wounds. Eur. J. Cell Biol. 94, 32-45. https://doi.org/10.1016/j.ejcb.2014.10.004
- Lau, E. and Ronai, Z.A. (2012). ATF2 - at the crossroad of nuclear and cytosolic functions. J. Cell Sci. 125, 2815-2824.
- Lin, C.H., Shih, C.H., Lin, Y.C., Yang, Y.L., and Chen, B.C. (2018). MEKK1, JNK, and SMAD3 mediate CXCL12-stimulated connective tissue growth factor expression in human lung fibroblasts. J. Biomed. Sci. 25, 19. https://doi.org/10.1186/s12929-018-0421-9
- Madden, E., Logue, S.E., Healy, S.J., Manie, S., and Samali, A. (2019). The role of the unfolded protein response in cancer progression: from oncogenesis to chemoresistance. Biol. Cell 111, 1-17. https://doi.org/10.1111/boc.201800050
- Meloche, S. and Pouyssegur, J. (2007). The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26, 3227-3239. https://doi.org/10.1038/sj.onc.1210414
- Murphy, L.O. and Blenis, J. (2006). MAPK signal specificity: the right place at the right time. Trends Biochem. Sci. 31, 268-275. https://doi.org/10.1016/j.tibs.2006.03.009
- Ojima, H., Masugi, Y., Tsujikawa, H., Emoto, K., Fujii-Nishimura, Y., Hatano, M., Kawaida, M., Itano, O., Kitagawa, Y., and Sakamoto, M. (2016). Early hepatocellular carcinoma with high-grade atypia in small vaguely nodular lesions. Cancer Sci. 107, 543-550. https://doi.org/10.1111/cas.12893
- Pang, Y., Zhao, Y., Wang, Y., Wang, X., Wang, R., Liu, N., Li, P., Ji, M., Ye, J., Sun, T., et al. (2020). TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1. J. Exp. Clin. Cancer Res. 39, 158. https://doi.org/10.1186/s13046-020-01658-z
- Sakamoto, M. (2009). Early HCC: diagnosis and molecular markers. J. Gastroenterol. 44 Suppl 19, 108-111. https://doi.org/10.1007/s00535-008-2245-y
- Sakamoto, M., Mori, T., Masugi, Y., Effendi, K., Rie, I., and Du, W. (2008). Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma. Intervirology 51 Suppl 1, 42-45.
- Shibata, R., Mori, T., Du, W., Chuma, M., Gotoh, M., Shimazu, M., Ueda, M., Hirohashi, S., and Sakamoto, M. (2006). Overexpression of cyclase-associated protein 2 in multistage hepatocarcinogenesis. Clin. Cancer Res. 12, 5363-5368. https://doi.org/10.1158/1078-0432.CCR-05-2245
- Shin, S., Buel, G.R., Nagiec, M.J., Han, M.J., Roux, P.P., Blenis, J., and Yoon, S.O. (2019). ERK2 regulates epithelial-to-mesenchymal plasticity through DOCK10-dependent Rac1/FoxO1 activation. Proc. Natl. Acad. Sci. U. S. A. 116, 2967-2976. https://doi.org/10.1073/pnas.1811923116
- Sisinni, L., Pietrafesa, M., Lepore, S., Maddalena, F., Condelli, V., Esposito, F., and Landriscina, M. (2019). Endoplasmic reticulum stress and unfolded protein response in breast cancer: the balance between apoptosis and autophagy and its role in drug resistance. Int. J. Mol. Sci. 20, 857. https://doi.org/10.3390/ijms20040857
- Urra, H., Dufey, E., Avril, T., Chevet, E., and Hetz, C. (2016). Endoplasmic reticulum stress and the hallmarks of cancer. Trends Cancer 2, 252-262. https://doi.org/10.1016/j.trecan.2016.03.007
- Wang, M. and Kaufman, R.J. (2014). The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat. Rev. Cancer 14, 581-597. https://doi.org/10.1038/nrc3800
- Woo, H.G., Choi, J.H., Yoon, S., Jee, B.A., Cho, E.J., Lee, J.H., Yu, S.J., Yoon, J.H., Yi, N.J., Lee, K.W., et al. (2017). Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer. Nat. Commun. 8, 839. https://doi.org/10.1038/s41467-017-00991-w
- Yadav, R.K., Chae, S.W., Kim, H.R., and Chae, H.J. (2014). Endoplasmic reticulum stress and cancer. J. Cancer Prev. 19, 75-88. https://doi.org/10.15430/JCP.2014.19.2.75
- Yoon, S., Choi, J.H., Kim, S.J., Lee, E.J., Shah, M., Choi, S., and Woo, H.G. (2019). EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression. Exp. Mol. Med. 51, 1-12.
- Zeisberg, M. and Neilson, E.G. (2009). Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest. 119, 1429-1437. https://doi.org/10.1172/JCI36183